Delcath Systems Inc (NAS:DCTH)
$ 11.48 -0.58 (-4.81%) Market Cap: 379.06 Mil Enterprise Value: 368.13 Mil PE Ratio: 0 PB Ratio: 37.52 GF Score: 62/100
Back to the Transcripts List

Q3 2024 Delcath Systems Inc Earnings Call Transcript

Nov 8, 2024 / 01:30 PM GMT
Release Date Price: $11.06 (+1.10%)

Key Points

Positve
  • Delcath Systems Inc (DCTH) reported strong revenue growth with $11.2 million in total revenue for Q3 2024, including $10 million from the U.S. market.
  • The company successfully activated 12 treatment centers by the end of the third quarter, with plans to reach 20 centers by early 2025.
  • Delcath Systems Inc (DCTH) achieved a significant milestone by triggering a $25 million financing from warrant exercises.
  • The company has no outstanding debt obligations, having fully matured and paid off loans with Avenue and Rosalind.
  • Delcath Systems Inc (DCTH) is in a strong financial position, with a cash flow break-even point on the horizon and adequate resources to fund further expansion.
Negative
  • The company anticipates a slowdown in treatment rates during the fourth quarter due to the holiday season, potentially affecting short-term revenue.
  • Research and development expenses are expected to increase significantly in 2025, ranging from $35 to $40 million, due to new clinical trials.
  • The activation process for new treatment centers is complex and time-consuming, with an average timeframe of 6 to 9 months.
  • Revenue from European operations remains modest, with the company managing the EU market on a breakeven basis.
  • There is uncertainty regarding the exact impact of seasonality on treatment rates and revenue, as the company navigates its first holiday season post-launch.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DCTH.OQ - Delcath Systems Inc
Q3 2024 Delcath Systems Inc Earnings Call
Nov 08, 2024 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the DCAS system. Third quarter, 2024 earnings call at this time, all participants are in a listen-only mode, a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Mr David Hoffman LCAT General Counsel. Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. And once again, welcome to DCAS Systems third quarter, 2024
Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.